Article info

Original research
RNA-binding protein RALY reprogrammes mitochondrial metabolism via mediating miRNA processing in colorectal cancer

Authors

  • Lei Sun National-Local Joint Engineering Laboratory of Druggability and New Drug Evaluation, National Engineering Research Center for New Drug and Druggability (cultivation), Guangdong Province Key Laboratory of New Drug Design and Evaluation, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, China PubMed articlesGoogle scholar articles
  • Arabella Wan Department of Gastrointestinal Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China PubMed articlesGoogle scholar articles
  • Zhuolong Zhou Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA PubMed articlesGoogle scholar articles
  • Dongshi Chen Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA PubMed articlesGoogle scholar articles
  • Heng Liang National-Local Joint Engineering Laboratory of Druggability and New Drug Evaluation, National Engineering Research Center for New Drug and Druggability (cultivation), Guangdong Province Key Laboratory of New Drug Design and Evaluation, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, China PubMed articlesGoogle scholar articles
  • Chuwei Liu Department of Gastrointestinal Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China PubMed articlesGoogle scholar articles
  • Shijia Yan National-Local Joint Engineering Laboratory of Druggability and New Drug Evaluation, National Engineering Research Center for New Drug and Druggability (cultivation), Guangdong Province Key Laboratory of New Drug Design and Evaluation, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, China PubMed articlesGoogle scholar articles
  • Yi Niu National-Local Joint Engineering Laboratory of Druggability and New Drug Evaluation, National Engineering Research Center for New Drug and Druggability (cultivation), Guangdong Province Key Laboratory of New Drug Design and Evaluation, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, China PubMed articlesGoogle scholar articles
  • Ziyou Lin National-Local Joint Engineering Laboratory of Druggability and New Drug Evaluation, National Engineering Research Center for New Drug and Druggability (cultivation), Guangdong Province Key Laboratory of New Drug Design and Evaluation, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, China PubMed articlesGoogle scholar articles
  • Siyue Zhan National-Local Joint Engineering Laboratory of Druggability and New Drug Evaluation, National Engineering Research Center for New Drug and Druggability (cultivation), Guangdong Province Key Laboratory of New Drug Design and Evaluation, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, China PubMed articlesGoogle scholar articles
  • Shanfeng Wang School of Materials Science and Engineering, Sun Yat-Sen University, Guangzhou, China PubMed articlesGoogle scholar articles
  • Xianzhang Bu National-Local Joint Engineering Laboratory of Druggability and New Drug Evaluation, National Engineering Research Center for New Drug and Druggability (cultivation), Guangdong Province Key Laboratory of New Drug Design and Evaluation, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, China PubMed articlesGoogle scholar articles
  • Weiling He Department of Gastrointestinal Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China Center for Precision Medicine, Sun Yat-Sen University, Guangzhou, China PubMed articlesGoogle scholar articles
  • Xiongbin Lu Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA Melvin and Bren Simon Cancer Center, Indiana University, Indianapolis, IN, USA PubMed articlesGoogle scholar articles
  • Anlong Xu School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China State Key Laboratory of Biocontrol, Guangdong Province Key Laboratory of Pharmaceutical Functional Genes, School of Life Sciences, Sun Yat-Sen University, Guangzhou, China PubMed articlesGoogle scholar articles
  • Guohui Wan National-Local Joint Engineering Laboratory of Druggability and New Drug Evaluation, National Engineering Research Center for New Drug and Druggability (cultivation), Guangdong Province Key Laboratory of New Drug Design and Evaluation, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, China PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Guohui Wan, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, China; wanguoh{at}mail.sysu.edu.cn; Professor Anlong Xu, School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China; xuanlong{at}bucm.edu.cn; Professor Xiongbin Lu, Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA; xiolu{at}iu.edu
View Full Text

Citation

Sun L, Wan A, Zhou Z, et al
RNA-binding protein RALY reprogrammes mitochondrial metabolism via mediating miRNA processing in colorectal cancer

Publication history

  • Received January 10, 2020
  • Revised October 8, 2020
  • Accepted October 27, 2020
  • First published November 20, 2020.
Online issue publication 
August 06, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.